Can a diabetes drug protect transplanted kidneys from damage?
NCT ID NCT04918407
First seen Nov 01, 2025 · Last updated Apr 29, 2026 · Updated 25 times
Summary
This study looked at whether adding empagliflozin (a diabetes medicine) to insulin can reduce oxidative stress—a type of cell damage—in people with type 2 diabetes who have received a kidney transplant. Forty adults with stable graft function took either empagliflozin plus insulin or insulin alone for 90 days. Researchers measured blood markers of oxidative stress to see if the combination offered extra protection.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for KIDNEY TRANSPLANT; COMPLICATIONS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Labbafinezhd Hospital
Tehran, 166663423, Iran
-
SBMU
Tehran, 1666664321, Iran
Conditions
Explore the condition pages connected to this study.